Literature DB >> 18547987

Endometriosis and angiogenesis.

K May1, C M Becker.   

Abstract

Endometriosis is a common gynecological condition, responsible for significant morbidity and social-economic impact. Although the condition has been recognized for many years, the underlying pathophysiology is poorly understood. In turn, this results in inadequate treatment and high recurrence rates. Various theories try to explain the presence of endometrial tissue outside the uterine cavity. However, none of them can explain all disease locations and appearances, and it is unclear how these fragments establish into endometriotic lesions. New vessel formation has long been recognized as a feature of endometriosis, often clearly visible at laparoscopy. Recent work has focused on identifying the role of vascularization in the pathogenesis of endometriosis, by allowing lesions to establish and grow. In this review the authors outline the basic mechanisms of angiogenesis and vasculogenesis in the human eutopic endometrium, and consider how this data can be applied to endometriotic implants. Furthermore, the authors discuss molecular mechanisms of angiogenesis and vasculogenesis, and how this may be used to therapeutic advantage in the treatment of endometriosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547987

Source DB:  PubMed          Journal:  Minerva Ginecol        ISSN: 0026-4784


  20 in total

Review 1.  Relating Chronic Pelvic Pain and Endometriosis to Signs of Sensitization and Myofascial Pain and Dysfunction.

Authors:  Jacqueline V Aredo; Katrina J Heyrana; Barbara I Karp; Jay P Shah; Pamela Stratton
Journal:  Semin Reprod Med       Date:  2017-01-03       Impact factor: 1.303

2.  Endometriosis-associated pain syndrome: a nurse-led approach.

Authors:  Julia Cambitzi; Maya Nagaratnam
Journal:  Br J Pain       Date:  2013-02

Review 3.  Drug delivery for the treatment of endometriosis and uterine fibroids.

Authors:  David R Friend
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

4.  Involvement of vascular endothelial growth factor -460 C/T, +405 G/C and +936 C/T polymorphisms in the development of endometriosis.

Authors:  Malgorzata Szczepańska; Adrianna Mostowska; Przemyslaw Wirstlein; Jana Skrzypczak; Paweł P Jagodziłski
Journal:  Biomed Rep       Date:  2014-12-19

Review 5.  Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications.

Authors:  Pamela Stratton; Karen J Berkley
Journal:  Hum Reprod Update       Date:  2010-11-23       Impact factor: 15.610

6.  MiR-199a inhibits the angiogenic potential of endometrial stromal cells under hypoxia by targeting HIF-1α/VEGF pathway.

Authors:  Lan Dai; Weihua Lou; Jie Zhu; Xingchen Zhou; Wen Di
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

7.  Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways.

Authors:  Cédric Carli; Christine N Metz; Yousef Al-Abed; Paul H Naccache; Ali Akoum
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

Review 8.  The role of lipoxin A4 in endometrial biology and endometriosis.

Authors:  G O Canny; B A Lessey
Journal:  Mucosal Immunol       Date:  2013-03-13       Impact factor: 7.313

9.  NME1 suppression of endometrial stromal cells promotes angiogenesis in the endometriotic milieu via stimulating the secretion of IL-8 and VEGF.

Authors:  Kai-Kai Chang; Li-Bing Liu; Li-Ping Jin; Yu-Han Meng; Jun Shao; Ying Wang; Jie Mei; Ming-Qing Li; Da-Jin Li
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

10.  VASCULAR ENDOTHELIAL GROWTH FACTOR SERUM LEVELS IN WOMEN WITH ADVANCED ENDOMETRIOSIS.

Authors:  A Malutan; T Drugan; C Georgescu; R Ciortea; C Bucuri; A Bobric; M P Rada; D Mihu
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jan-Mar       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.